Status:

RECRUITING

A Ketamine-assisted Group Therapy Intervention for Spanish-speaking Adults With Depression

Lead Sponsor:

Juliana Zambrano, MD, MPH

Conditions:

Depression

Eligibility:

All Genders

18-64 years

Phase:

PHASE1

PHASE2

Brief Summary

This is a pilot clinical trial to assess the feasibility, safety, and preliminary efficacy of ketamine-assisted group therapy for Spanish-speaking adults with depression

Eligibility Criteria

Inclusion

  • 1\. Self-identifying Latinx, Spanish-speaking 2. Adults 18-64 years 3. Meet DSM-5 criteria for major depressive disorder as evaluated by study clinician 4. Montgomery-Asberg depression scale (MADRS) score of 20 or above at baseline 4. Participants must have an MGB psychiatrist and primary care provider.

Exclusion

  • History of primary psychotic disorder, by history
  • History Bipolar I disorder, by history
  • Unstable complex PTSD, as assessed by study clinician
  • History of dissociative identity disorder
  • History of neurocognitive disorder
  • History of severe and/or recent substance use disorder, by history and as assessed by study clinician after clinical evaluation and interview
  • Uncontrolled hypertension, tachycardia, or unstable cardiopulmonary disease, by history a. Blood pressure on initial screen must be \<140/90 mmHg.
  • History of aortic dissection
  • History of myocardial infarction
  • History of aneurysm
  • History of hepatic impairment.
  • History of epilepsy
  • History of prior hypersensitivity to ketamine
  • Body Mass Index greater than 35
  • Body Mass Index less than 18.5
  • Are pregnant, breastfeeding, or planning to become pregnant within 12 weeks of treatment completion
  • Enrolled in other clinical trial for the treatment of depression or other behavioral health diagnosis
  • Inability to provide consent.

Key Trial Info

Start Date :

July 23 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06597695

Start Date

July 23 2025

End Date

July 1 2026

Last Update

July 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital, Chelsea

Chelsea, Massachusetts, United States, 02114